Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. - Bedir, Şahin; Kapagan, Tanju; Çakan Demirel, Burçin; Tokocin, Merve; Yıldırım, Çiğdem; Taş, Semra; Bozkaya, Yakup; Oyman, Abdilkerim; Bulut, Nilufer; Erdem, Gökmen Umut (Journal of Clinical Medicine, 2026)